NCT02130505View on ClinicalTrials.gov

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
AtherosclerosisLeukocyte Activation DisorderType 2 Diabetes MellitusFamilial Combined Hyperlipidemia
Interventions
DIETARY_SUPPLEMENT

OGTT

Oral glucose tolerance test (OGTT) with 75 g of oral anhydrous glucose

All Listed Sponsors
lead

Sint Franciscus Gasthuis

OTHER

NCT02130505 - Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes | Biotech Hunter | Biotech Hunter